These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12095406)

  • 1. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants.
    Puddy VF; Amirmansour C; Williams AF; Singer DR
    Clin Sci (Lond); 2002 Jul; 103(1):75-7. PubMed ID: 12095406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
    Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
    Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks.
    Czernik C; Lemmer J; Metze B; Koehne PS; Mueller C; Obladen M
    Pediatr Res; 2008 Sep; 64(3):286-90. PubMed ID: 18414139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.
    Ramakrishnan S; Heung YM; Round J; Morris TP; Collinson P; Williams AF
    Acta Paediatr; 2009 Aug; 98(8):1254-9. PubMed ID: 19432837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.
    Sanjeev S; Pettersen M; Lua J; Thomas R; Shankaran S; L'Ecuyer T
    J Perinatol; 2005 Nov; 25(11):709-13. PubMed ID: 16222347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants.
    El-Khuffash AF; Slevin M; McNamara PJ; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F133-7. PubMed ID: 21071684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?
    Lee JH; Shin JH; Park KH; Rhie YJ; Park MS; Choi BM
    Neonatology; 2013; 103(2):118-22. PubMed ID: 23182972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
    Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
    Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
    Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
    Letshwiti JB; Sirc J; O'Kelly R; Miletin J
    Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ; Smith A; Littleton P; Carter N; Hamilton PA
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates.
    Flynn PA; da Graca RL; Auld PA; Nesin M; Kleinman CS
    J Pediatr; 2005 Jul; 147(1):38-42. PubMed ID: 16027692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.
    El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of brain natriuretic propeptide in the diagnosis and management of patent ductus arteriosus].
    Montaner Ramón A; Galve Pradel Z; Fernández Espuelas C; Jiménez Montañés L; Samper Villagrasa MP; Rite Gracia S
    An Pediatr (Barc); 2017 Jun; 86(6):321-328. PubMed ID: 26936584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M; Gokulakrishnan G; Price J; Fernandes CJ; Leeflang M; Pammi M
    Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes of brain-type natriuretic peptide in preterm neonates.
    da Graca RL; Hassinger DC; Flynn PA; Sison CP; Nesin M; Auld PA
    Pediatrics; 2006 Jun; 117(6):2183-9. PubMed ID: 16740863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus.
    Kalra VK; DeBari VA; Zauk A; Kataria P; Myridakis D; Kiblawi F
    Ann Clin Lab Sci; 2011; 41(2):131-7. PubMed ID: 21844570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.